Tag Archives: Elie Wiesel

Ethics in Drug Innovation: The First Hurdle is Trust

By Ansis Helmanis Ethics is a matter of trust, which in the regulatory space requires transparency and openness among all stakeholders, including patients and industry.  This was the consensus of FDA Commissioner Margaret Hamburg and European Medicines Agency (EMA) Executive Director Guido Rasi, both of whom shared the podium with Nobel Laureate Professor Elie Wiesel […]
Posted in Europe, Events, FDA, Global, Guest Blog, healthcare, leadership, Market Access, Patient Communication, pricing, Regulatory | Also tagged , , , , , , , | Leave a comment

Pharma Celebrates its Own

At the gala ceremony for the 2009 Prix Galien USA award on October 1, a paradigm shift in drug development took center stage. “The most successful new [cancer] therapies will be based on a precise molecular understanding of disease basis—that’s exactly what we did with Gleevec,” said keynote speaker Brian Druker, director of the Oregon […]
Posted in Events | Also tagged , , , , , , , , , , , , | Leave a comment

Simply Genius: Prix Galien USA 2008 (photos)

Click here to view a slideshow from Prix Galien 2008 The 2008 Prix Galien USA is in the books, and Pharm Exec was in attendance at New York’s Museum of Natural History to take in all the festivities. Pfizer, Merck, Alexion, Wyeth, and Celgene were all recognized for their work in advancing science in both […]
Posted in Biotech, Events, People | Also tagged , , , , , , , | Leave a comment
  • Categories

  • Meta